Next Article in Journal
Comparison of Two Diagnostic Methods for the Detection of Hepatitis B Virus Genotypes in the Slovak Republic
Next Article in Special Issue
Schistosoma mansoni Adult Worm Protective and Diagnostic Proteins in n-Butanol Extracts Revealed by Proteomic Analysis
Previous Article in Journal
Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General
Previous Article in Special Issue
From the One Health Perspective: Schistosomiasis Japonica and Flooding
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages

by
Kathrin Arndts
1,
Tayseer E. M. Elfaki
2,
Michael J. Doenhoff
3,
Gnatoulma Katawa
4,
Ibtisam A. Goreish
5,
Misk El Yemen A. Atti El Mekki
2,
Achim Hoerauf
1,6,7,
Manuel Ritter
1 and
Laura E. Layland
1,6,*
1
Institute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, Germany
2
Department of Parasitology and Medical Entomology, College of Medical Laboratory Science, Sudan University of Science and Technology, Khartoum 13311, Sudan
3
School of Life Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK
4
Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), University of Lome, Lomé BP 1515, Togo
5
Animal Resources Research Corporation, Ministry of Livestock, Fisheries and Rangelands, Khartoum 13311, Sudan
6
German Centre for Infection Research (DZIF), Neglected Tropical Disease, Partner Site, Bonn-Cologne, 53127 Bonn, Germany
7
German-West African Centre for Global Health and Pandemic Prevention (G-WAC), Partner Site Bonn, 53127 Bonn, Germany
*
Author to whom correspondence should be addressed.
Pathogens 2022, 11(1), 19; https://doi.org/10.3390/pathogens11010019
Submission received: 11 October 2021 / Revised: 10 December 2021 / Accepted: 16 December 2021 / Published: 24 December 2021
(This article belongs to the Special Issue Schistosomiasis: Host-Pathogen Biology)

Abstract

:
Despite the existence of an effective medication against schistosomiasis, the disease remains a major health problem in affected areas, especially for those lacking appropriate sanitary facilities. Moreover, treatment cannot prevent re-infection since it is only effective on adult schistosome worms. Previous retrospective studies in the Sudan have discovered unique immuno-epidemiological profiles in uninfected individuals and those positive for Schistosoma mansoni via polymerase chain reaction (PCR) but egg-negative and those with eggs in their stool. Expanding on these data, serum samples from these individuals were further investigated for the presence of cercarial (SmCTF)-specific antibodies, which would indicate immune responses at the early stages of infection. Indeed, SmCTF IgG1, 2, 3 and 4 levels were significantly elevated in SmPCR+ individuals when compared to egg+ patients. Following multivariable regression analysis, including SmCTF-specific Igs, Schistosoma egg antigen (SEA)-specific and Schistosoma worm antigen (SWA)-specific immunoglobulins revealed a specific immunoglobulin (Ig) profile of individuals presenting different states of infection, which may be a useful future tool in order to identify egg individuals and thereby prevent unnecessary treatments.

1. Introduction

In a recent study from Cha et al., it was revealed that schistosomiasis continues to burden populations in non-stable communities of the Sudan [1]. In correlation with our previous studies from the Sudan [2,3], Cha and colleagues also found strong associations between infection and available latrines—since infections are obtained in fresh water sources from snails releasing cercariae, the infectious stage. Thus, despite large-scale programmes designed to tackle schistosomiasis [4], this chronic helminth infection remains a severely neglected tropical disease in the Sudan [5]. Such programmes are costly and logistically challenging, and the frequency of treatment is determined by the prevalence of infection [6]. In high transmission areas, treatment may have to be repeated every year for a number of years, adding further difficulties to ensure compliance within the communities. Cha and colleagues also revealed over 2 million people would not benefit from schistosome-specific mass drug administration (MDA) in community-wide programmes with 75% coverage, despite high endemicity (8% for schistosomiasis) [1]. Moreover, 1.7 million people would receive the drug unnecessarily, which can drive the reduction in drug susceptibility and even resistance [7]. Treatment for schistosomes remains praziquantel, an effective, quick-acting drug that kills adult worms but has no effect on earlier stages in the host and does not stop re-infections [8,9,10]. Thus, research to prevent infection requires newer approaches for alternative drugs and vaccines, and this should be coupled with limiting contact with infectious sources, such as available latrines at home, schools and washing stations [11].
Using a combination of diagnostic techniques, our earlier studies on a cohort of Sudanese individuals living in a Schistosoma mansoni-endemic area revealed a further subset of infected individuals that were positive for S. mansoni via PCR but had no detectable eggs in stool samples [2,3]. This group could be individuals with dying, menopausal or single worm infections, or an early infection. In terms of schistosome-specific antibody levels, this group showed increased levels of worm-specific IgG2 [3] but lower egg-specific IgG4 levels when compared to egg-positive individuals [2].
When free-living cercariae penetrate the mammalian host’s skin and lose their bifurcated tails in a process termed “transformation” to become schistosomulae [12,13], which linger for a few days, this elicits a local immune response in the dermis and dermal cells [14,15,16,17]. To expand on the profile of individuals presenting a SmPCR+egg state, we determined the levels of antibodies in a S. mansoni cercarial antigen preparation (called cercarial transformation fluid—SmCTF, described by Smith et al., 2012) [12] to identify whether the variations on “early-stage” antibodies are also different between the groups.

2. Results

2.1. All Measured SmCTF-specific IgGs Are Elevated in SmPCR+ Individuals

Immuno-epidemiological research hypothesizes that individuals with elevated levels of anti-schistosome IgG4 are more susceptible to infection, whereas those with high anti-schistosome IgE are protected against re-infection [18,19]. Few studies however, have investigated the relationship between the parasite stage-specific antibody production and a clinical diagnostic status. Our previous studies identified a further cohort—namely SmPCR+egg individuals [2,3]. Upon testing egg (SEA)- or worm (SWA)-specific antibody levels, we determined that both infected groups (egg+ and SmPCR+) had higher SWA-specific IgG3 and IgG4, and SEA-specific IgG4, than uninfected individuals. Moreover, SWA-specific IgG2 antibody levels were higher in the SmPCR+ group when compared to egg+ individuals. In experiments performed here—using extracts from cercarial life-stages—we assessed SmCTF-specific Ig levels in the same cohort (Figure 1). The levels of SmCTF-specific IgG1, IgG2, IgG3 and IgG4 were significantly higher in the SmPCR+ group when compared to both uninfected and egg+ cohorts (Figure 1A–D). With regards to SmCTF-specific IgE levels, reduced levels were observed in egg+ individuals when compared to both other groups, albeit not significantly (Figure 1E).

2.2. SmCTF IgG1 Levels Are Associated with SmPCR+ Individuals

The correlation analysis of egg load and levels of SmCTF-specific Igs revealed a significant negative correlation with IgG1 (r = − 0.235, p > 0.001), IgG2 (r = − 0.151, p = 0.022) and IgG3 (r = − 0.265, p > 0.001). If the age was correlated to the SmCTF-specific Igs, a significant correlation with SmCTF-specific IgE (r = 0.230, p < 0.001) and IgG4 (r = 0.147, p = 0.026) was detected. An additional analysis revealed significantly higher levels of SmCTF IgG1 and IgG3 in the “young”aged SmPCR+ group when compared to “young” aged egg+ individuals. Several differences were also observed in the “adolescent” group since IgG1, IgG2 and IgG3 levels significantly increased in the SmPCR+ cohort when compared to either Sm uninf or egg+ individuals. Additionally, in the “adolescent” cohort, both SmPCR+ and egg+ IgG4 levels were higher than in the Sm uninf group. No differences were observed in the adult population (Supplementary Figure S1).
In order to include “early-stage” antibodies in our immunoprofiling of the investigated participants, we performed an initial regression analysis to determine associations of SmCTF-specific Ig levels with age or data on exposure. Whereas infection per se, was associated with SmCTF-specific IgG4 levels, there was no significant association when comparing egg+ individuals with uninfected participants (Table 1). In contrast, a SmPCR+ status was more linked to elevated SmCTF-specific IgG1 levels when compared to uninfected individuals. The same outcome was observed when comparing SmPCR+ and egg+ individuals and, additionally, the first group was also associated with SmCTF-specific IgG3 levels, whereas an egg+ S. mansoni infection was associated with SmCTF-specific IgG2 levels. Associations with age groups in context with SmCTF-specific Igs were consistent with our previous results; thus, younger (4–9 years old) individuals were more prone to belong to the infected groups (either SmPCR+ or egg+), whereas between these two groups there was no significant association.

2.3. Strong Association of SEA-Specific IgG4 with Infection

Next, a multivariate regression analysis was performed following a combination of all measured SEA- and SWA-specific Igs from our previous studies (Elfaki, 2016, Arndts, 2019) with our new data gathered in this study (Table 2). Interestingly, SEA-specific IgG4 remained the only schistosome-specific Ig strongly associated with infection per se, and SEA-specific IgE was highly associated with egg+ individuals when compared to SmPCR+ individuals. This profile now includes SmCTF IgG2 when compared to the SmPCR+ cohort. In contrast, the SmPCR+ group was more associated with SmCTF-specific IgG3 and IgG1, and uninfected individuals showed associations with SmCTF-specific IgG4 when compared with egg+ but not SmPCR+ individuals. Thus, the picture shown in Figure 2 confirms that individuals with different infection states present different schistosome life stage-specific Igs. Thus, the analysis of schistosome stage-specific antibody levels might be a novel tool to decipher the stage of S. mansoni infections.

3. Discussion

Within this retrospective study using serum samples from a cohort from the Sudan, we could show that SmCTF-specific IgG1-4 are higher in SmPCR+ individuals when compared to egg+ individuals, highlighting again how schistosome-specific antibody levels change during the different infection stages. Combining all evaluated schistosome-specific Ig data sets together from previous studies with the same cohort, using multivariate regression analysis [2,3], supported these findings since egg+ individuals were characterised by elevated SmCTF-specific IgG2, SEA-specific IgG4 and IgE levels in comparison to SmPCR+ individuals. The latter were associated with elevated SmCTF-specific IgG3 and 1 levels.
Although control programmes started more than 40 years ago in the Sudan, schistosomiasis is still endemic in all states of the country, except the Red Sea State [20], especially among the inhabitants of fragile and conflict-affected areas [21]. Assessments from the Sudanese Ministry of Health state that more than eight million people are at risk of schistosomiasis [1], and an estimated 5.8 million people (around 15% of the total population) require treatment [20]. In order to improve effective antihelminthic treatments as well as prevention of unnecessary treatment, in-depth knowledge about host–parasite interaction is needed, including schistosome-specific antibody responses [22]. The detection of anti-schistosomal antibodies is a useful addition to microscopy [23] since the latter technique is time consuming, requires expertise and has limited sensitivity in cases of low egg secretion. Moreover, antibody tests can be run in larger batches.
Initial infections by schistosomes can already occur in young children, whereas in adolescence, infections decline, implicating the development of a type of immunity that hinders re-infection [24,25,26]. Previous immuno-epidemiological studies could show that elevated levels of anti-schistosome IgG4 are associated with parasitic susceptibility, whereas anti-schistosome IgE antibodies induce resistance to re-infection [18,19]. The association between the high levels of anti-larval IgE and the resistance to a schistosoma infection was previously described [27]. However, we observed the lowest levels of SmCTF-specific IgE in our infected egg+ group. A correlation analysis of all SmCTF isotypes and age only revealed a significant, positive correlation for SmCTF-specific IgE in line with the lower age within the group of egg+ individuals, as shown previously [2,3]. In 2013, Coulibaly et al. showed in a study performed in Cote d’Ivoire that SmCTF-specific rapid diagnostic tests were comparable in terms of sensitivity when tested against Kato–Katz techniques and therefore interesting candidates for mapping the prevalence of anti-schistosome antibodies in a given population pending intervention [28]. Nausch and colleagues further confirmed these data in a study from an endemic area in Zimbabwe [29]. The detection of the early stages of schistosoma infection is favourable, especially before the egg deposition in the host tissues, as the development of severe pathology would be efficiently prevented [30]. Moreover, the cercarial antigen preparation is more easily produced than SEA [23] and was shown to perform equivalently to SEA in ELISA in the detection of anti-schistosome antibodies in sera of infected individuals [12]. Thus, the SmCTF antigen may be an interesting candidate to measure serum samples of exposed individuals from endemic areas either lacking MDA, or only applying MDA after the detection of eggs in stool samples, to get a hint about potential egg-free infections that might require treatment—or the other way round—in order to prevent unnecessary treatments in children. In addition, it would be interesting to measure the functionality of such stage-specific antibodies in future studies, e.g., through co-cultivation experiments of isolated immunoglobulins and granulocytes.
Although there is a general paucity of clinical studies investigating the relationship between specific antibody production and its impact on the severity of the infection, some studies have detected increased levels of SEA-specific IgG4 in patients with severe pathology [31,32]. Even though our participants were not examined clinically, and therefore we cannot draw any conclusions about symptomatic responses, the data obtained from the combined regression analysis on the same cohort indicate that the measurement of SEA IgG4 levels might be an interesting tool in order to identify egg but infected individuals. Moreover, future studies might apply our combined panel of stage-specific Ig measurements to correlate it to different pathologic stages or to create a lateral flow test with all three antigens for an easy/non-invasive application in the field. The lack of consecutive stool sampling might be initially seen as a limitation of the study; on the other hand, it propagated this entire research project since, upon initial analysis of some parameters, we noted that the non-infected cohort had two distinct groups. However, future studies should therefore focus on molecular techniques that are field-applicable, such as LAMP assays, to detect schistosome infection in egg-free individuals.
In conclusion, the determination of combined antibody profiles (SEA-, SWA- and SmCTF-specific) might allow for a more fine-tuned status of infection, e.g., if egg individuals have elevated SmCTF-specific IgG1-4 levels, this would indicate a pre-patent point of infection; if they present increased SEA IgG4 levels, they might harbour old female worms that are no longer fertile any more. All of the generated data would help to prevent unnecessary treatments that are challenging in terms of logistics in remote areas and economics. For future studies in other endemic countries, using the same diagnostic parameters could determine if the stage-specific Ig-profiling revealed here is reflected in other cohorts. This would strongly substantiate both diagnostics and the respective profiling. A potential scenario to investigate these profiles could be conducted during deworming programmes.

4. Methods

4.1. Epidemiological Profiling and Serum Collection

Between March and October 2011, a survey was performed by the Ministry of Health in Kassala and Khartoum State to estimate the prevalence and intensity of schistosomiasis (n = 770), as already published [2,3]. Ethical clearance was approved by the Ministry of Health-Kassala State Department of Preventive Medicine Office of the anti-bilharzia and intestinal worms, New Halfa City. All individuals gave their oral informed consent, and children were only included if we received oral consent provided by a parent or legal guardian. Written consent was not necessary since the sampling procedures were always performed in the presence of a Ministry of Health representative. All individuals provided one stool sample, out of which three slides were prepared to check for the presence of parasitic eggs using the Kato–Katz technique. Within the egg+ group, the S. mansoni egg load ranged from 24 to 960 eggs/g faeces (mean = 72). In addition, urine samples were also analysed for S. haematobium infection. All samples were negative for S. haematobium eggs, Taenia saginata infections and for soil-transmitted helminths such as Ascaris lumbricoides, Trichuris trichiura and hookworms. For epidemiological purposes, the study participants also completed a questionnaire (e.g., health, available latrines, education etc.) on which the examiner noted their oral consent. The participants also provided a venous blood sample (approximately 5 mL), which was drawn into Vacutainer tubes (BD Biosciences Heidelberg, Germany) containing no coagulants. After five hours at room temperature, the serum was aspirated off the clot, aliquoted into cryotubes and stored at −80 °C [2,3].

4.2. Schistosome-Specific Diagnostics and Groupings

The presence of helminth infection was primarily diagnosed in the field within stool samples from each study participant. Using the Kato–Katz technique, 110 individuals were identified as being positive for S. mansoni eggs (egg+). No S. haematobium eggs were detected in urine samples [2]. A schistosome-specific PCR [2] was also performed on serum samples, and egg-negative individuals were then further divided into uninfected (Sm uninf, n = 61) and SmPCR+ egg-negative (n = 63) cohorts. An overview of the entire cohort is depicted in Elfaki et al. [2].

4.3. Determination of SmCTF Immunoglobulins

A cercarial antigen extract of S. mansoni cercariae was prepared, as described in Chand et al. [23]. The levels of SmCTF-specific IgG1-4 and IgE were determined using serum samples from included participants. In short, 96-well polysorb plates (Nunc, Roskilde, Denmark) were coated overnight (50 µL/well) at 4 °C with 5 µg/mL of SmCTF (BioGlab Ltd., Nottingham, UK) diluted in PBS (pH 9.6). Afterwards, plates were washed three times with washing buffer (PBS, 0.05% Tween 20, pH 7.2 (Sigma-Aldrich, Munich, Germany)), followed by a washing step using 1 x PBS. Subsequently, a blocking step was then performed for one hour at room temperature (RT) using 200 µL/well of blocking buffer (PBS/1% BSA). The washing procedure was repeated, and 50 µL/well of diluted serum (1:500 for IgG1-IgG4 and 1:20 for IgE) was added to the wells. Following an overnight incubation at 4 °C, the plates were washed again, and the biotinylated secondary antibodies (IgG1: 1:1000, IgG2: 1:4000, IgG3: 1:4000, IgG4 1:15,000, all Sigma-Aldrich, IgE 1:1000, Southern Biotech, Birmingham, USA) were added to the appropriate wells (50 µL/well) for two hours at RT, followed by the wash procedure. In the next step, 50 µL/well of streptavidin-horse radish peroxidase (Roche Diagnostics, Mannheim, Germany; 1:5000) was added to each well and incubated for 45 min at room temperature. After the last washing step, 50 µL/well of substrate solution, containing tetramethylbenzidine (Sigma-Aldrich), was added to the wells. After 15 min, the reactions were stopped using 25 µL/well 2N H2SO4 (Merck KGAA, Darmstadt, Germany). The optical density was measured with a wavelength correction (450 nm and 570 nm) using a SpectraMAX ELISA reader (Molecular Devices, Sunnyvale, USA), and data were evaluated with the SOFTmax Pro 3.0 software (Molecular Devices).

4.4. Statistical Analysis

The data were statistically analysed using the software SPSS (IBM SPSS Statistics 22; Armonk, NY) and GraphPad PRISM version 5.02 for Windows (GraphPad Software, Inc., La Jolla, USA). The variables did not meet assumptions to allow parametric analysis; therefore, to compare the three groups, a Kruskal–Wallis test was performed and, if significant, followed by a Mann–Whitney U-test for further pairwise comparison of the groups. p values of less than 0.05 were considered statistically significant. For comparisons of continuous parameters, the Spearman correlation test was used. In order to determine potential indicators for the different infection statuses (‘infected versus non-infected’, ‘egg+ versus Sm uninf’, ‘SmPCR+ versus Sm uninf’ and ‘SmPCR+ versus egg+’), epidemiological and Ig data were assessed using two sets of a binary logistic regression model. Epidemiological covariates included age (subgrouped into “young” (4–9 years old), “adolescent” (10–19 years old), and “adult” (20–80 years old)), and “exposure” and “non exposure” (referring to individual daily water sources), as described in Elfaki et al. 2016. In the first approach, the mentioned epidemiological covariates were assessed with all SmCTF immunoglobulins in a stepwise logistic regression with forward selection using thresholds of p < 0.1 for the entry of variables into the model. The odds ratio (OR), 95% confidence intervals (CI) and p values were used as estimates of the effect of each variable. In a second analysis, we combined SEA- and SWA-specific Ig data from the first two publications [2,3], with the new SmCTF data measured here.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/pathogens11010019/s1, Figure S1: Highest levels of SmCTF-specific IgGs in adolescent individuals.

Author Contributions

L.E.L. designed and implemented the study. T.E.M.E., I.A.G. and M.E.Y.A.A.E.M. performed patient recruitment and field work. K.A. performed and analysed the Ig data, and interpreted the results with L.E.L. K.A. designed and assessed the multivariable regression analysis. M.J.D. contributed the reagents/materials/analysis tools. M.R., A.H. and G.K. critically assessed the manuscript after it was written by K.A. and L.E.L. All authors read and approved the final manuscript.

Funding

TEME received a fellowship awarded by the German Academic Exchange Committee (DAAD). This study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft—DFG; Grant LA 2746/2-1) within the “German-African Cooperation Projects in Infectiology” through grants awarded to L.E.L and G.K. Furthermore, A.H. is supported by the German Federal Ministry of Education and Research (BMBF) [01KA1611 and 01KA2027] and is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy—EXC2151—390873048.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of the Ministry of Health-Kassala State Department of Preventive Medicine Office of the anti-bilharzia and intestinal worms, New Halfa City.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study and was carried out in presence of a Ministry of Health representative.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical restrictions.

Acknowledgments

We thank the entire Sudan-based research team for help with the recruitment of study participants.

Conflicts of Interest

The authors of this work have no financial, personal or professional interests that could have been construed to influence this manuscript.

References

  1. Cha, S.; Elhag, M.S.; Lee, Y.H.; Cho, D.S.; Ismail, H.; Hong, S.T. Epidemiological findings and policy implications from the nationwide schistosomiasis and intestinal helminthiasis survey in sudan. Parasit Vectors 2019, 12, 429. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Elfaki, T.E.; Arndts, K.; Wiszniewsky, A.; Ritter, M.; Goreish, I.A.; Atti El Mekki, M.E.; Arriens, S.; Pfarr, K.; Fimmers, R.; Doenhoff, M.; et al. Multivariable regression analysis in Schistosoma mansoni-infected individuals in the sudan reveals unique immunoepidemiological profiles in uninfected, egg+ and non-egg+ infected individuals. PLoS Negl. Trop. Dis. 2016, 10, e0004629. [Google Scholar] [CrossRef] [PubMed]
  3. Arndts, K.; Elfaki, T.E.M.; Jelden, N.; Ritter, M.; Wiszniewsky, A.; Katawa, G.; Goreish, I.A.; El Mekki, M.; Doenhoff, M.J.; Hoerauf, A.; et al. Schistosoma mansoni pcr+ infected individuals in the sudan present elevated systemic levels of chemokines when compared to uninfected and egg+ cohorts. Clin. Exp. Immunol. 2019, 196, 364–373. [Google Scholar] [CrossRef]
  4. WHO. Sudan Intensifies Its Fight against Schistosomiasis through Large-Scale Treatment of School-Age Children. Available online: https://www.who.int/news/item/02-09-2013-sudan-intensifies-its-fight-against-schistosomiasis-through-large-scale-treatment-of-school-age-children (accessed on 20 December 2021).
  5. Charani, E.; Cunnington, A.J.; Yousif, A.H.A.; Seed Ahmed, M.; Ahmed, A.E.M.; Babiker, S.; Badri, S.; Buytaert, W.; Crawford, M.A.; Elbashir, M.I.; et al. In transition: Current health challenges and priorities in sudan. BMJ Glob. Health 2019, 4, e001723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Elhag, M.S.; Jin, Y.; Amin, M.A.; Ismail, H.; Hong, S.T.; Jang, H.I.; Doh, Y.; Cha, S. Cost and logistics implications of a nationwide survey of schistosomiasis and other intestinal helminthiases in sudan: Key activities and cost components. PLoS ONE 2020, 15, e0226586. [Google Scholar] [CrossRef]
  7. Vale, N.; Gouveia, M.J.; Rinaldi, G.; Brindley, P.J.; Gartner, F.; Correia da Costa, J.M. Praziquantel for schistosomiasis: Single-drug metabolism revisited, mode of action, and resistance. Antimicrob. Agents Chemother 2017, 61, e02582-16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Bergquist, R.; Utzinger, J.; Keiser, J. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? Infect. Dis. Poverty 2017, 6, 74. [Google Scholar] [CrossRef] [Green Version]
  9. McManus, D.P.; Dunne, D.W.; Sacko, M.; Utzinger, J.; Vennervald, B.J.; Zhou, X.N. Schistosomiasis. Nat. Rev. Dis. Primers 2018, 4, 13. [Google Scholar] [CrossRef]
  10. Dunn, D.; Vennerwald, B. Schistosomiasis. In Oxford Textbook of Medicine, 6th ed.; Oxford University Press: Oxford, UK, 2020. [Google Scholar]
  11. Grimes, J.E.; Croll, D.; Harrison, W.E.; Utzinger, J.; Freeman, M.C.; Templeton, M.R. The relationship between water, sanitation and schistosomiasis: A systematic review and meta-analysis. PLoS Negl. Trop. Dis. 2014, 8, e3296. [Google Scholar] [CrossRef] [PubMed]
  12. Smith, H.; Doenhoff, M.; Aitken, C.; Bailey, W.; Ji, M.; Dawson, E.; Gilis, H.; Spence, G.; Alexander, C.; van Gool, T. Comparison of Schistosoma mansoni soluble cercarial antigens and soluble egg antigens for serodiagnosing schistosome infections. PLoS Negl. Trop. Dis. 2012, 6, e1815. [Google Scholar] [CrossRef]
  13. Egesa, M.; Lubyayi, L.; Tukahebwa, E.M.; Bagaya, B.S.; Chalmers, I.W.; Wilson, S.; Hokke, C.H.; Hoffmann, K.F.; Dunne, D.W.; Yazdanbakhsh, M.; et al. Schistosoma mansoni schistosomula antigens induce th1/pro-inflammatory cytokine responses. Parasite Immunol. 2018, 40, e12592. [Google Scholar] [CrossRef]
  14. Hayunga, E.G.; Mollegard, I.; Duncan, J.F., Jr.; Sumner, M.P.; Stek, M., Jr.; Hunter, K.W., Jr. Early diagnosis of Schistosoma mansoni in mice using assays directed against cercarial antigens isolated by hydrophobic chromatography. J. Parasitol. 1987, 73, 351–362. [Google Scholar] [CrossRef]
  15. Kanamura, H.Y.; Hoshino-Shimizu, S.; da Silva, L.C. Schistosoma mansoni cercaria and schistosomulum antigens in serodiagnosis of schistosomiasis. Bull. Pan. Am. Health Organ. 1992, 26, 220–229. [Google Scholar]
  16. Winkel, B.M.F.; Dalenberg, M.R.; de Korne, C.M.; Feijt, C.; Langenberg, M.C.C.; Pelgrom, L.; Ganesh, M.S.; Yazdanbakhsh, M.; Smits, H.H.; de Jong, E.C.; et al. Early induction of human regulatory dermal antigen presenting cells by skin-penetrating Schistosoma mansoni cercariae. Front. Immunol. 2018, 9, 2510. [Google Scholar] [CrossRef] [PubMed]
  17. Anisuzzaman, S.F.; Prodjinotho, U.F.; Bhattacharjee, S.; Verschoor, A.; Prazeres da Costa, C. Host-specific serum factors control the development and survival of Schistosoma mansoni. Front. Immunol. 2021, 12, 635622. [Google Scholar] [CrossRef] [PubMed]
  18. Hagan, P.; Blumenthal, U.J.; Dunn, D.; Simpson, A.J.; Wilkins, H.A. Human ige, igg4 and resistance to reinfection with Schistosoma haematobium. Nature 1991, 349, 243–245. [Google Scholar] [CrossRef]
  19. Dunne, D.W.; Butterworth, A.E.; Fulford, A.J.; Kariuki, H.C.; Langley, J.G.; Ouma, J.H.; Capron, A.; Pierce, R.J.; Sturrock, R.F. Immunity after treatment of human schistosomiasis: Association between ige antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 1992, 22, 1483–1494. [Google Scholar] [CrossRef] [PubMed]
  20. Amin, M.; Abubaker, H. Control of schistosomiasis in the gezira irrigation scheme, sudan. J. Biosoc. Sci. 2017, 49, 83–98. [Google Scholar] [CrossRef]
  21. Sokolow, S. The History of Schistosomiasis in Sudan. Available online: https://schisto.stanford.edu/pdf/Sudan%20and%20South%20Sudan.pdf (accessed on 20 December 2021).
  22. Fukushige, M.; Mutapi, F.; Woolhouse, M.E.J. Population level changes in schistosome-specific antibody levels following chemotherapy. Parasite Immunol. 2019, 41, e12604. [Google Scholar] [CrossRef] [PubMed]
  23. Chand, M.A.; Chiodini, P.L.; Doenhoff, M.J. Development of a new assay for the diagnosis of schistosomiasis, using cercarial antigens. Trans. R. Soc. Trop. Med. Hyg. 2010, 104, 255–258. [Google Scholar] [CrossRef]
  24. Katabarwa, M.N.; Eyamba, A.; Nwane, P.; Enyong, P.; Yaya, S.; Baldiagai, J.; Madi, T.K.; Yougouda, A.; Andze, G.O.; Richards, F.O. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in north region, cameroon. Am. J. Trop. Med. Hyg. 2011, 85, 1041–1049. [Google Scholar] [CrossRef] [PubMed]
  25. Wilson, S.; Jones, F.M.; Fofana, H.K.; Doucoure, A.; Landoure, A.; Kimani, G.; Mwatha, J.K.; Sacko, M.; Vennervald, B.J.; Dunne, D.W. Rapidly boosted plasma il-5 induced by treatment of human schistosomiasis haematobium is dependent on antigen dose, ige and eosinophils. PLoS Negl. Trop. Dis. 2013, 7, e2149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Colley, D.G.; Bustinduy, A.L.; Secor, W.E.; King, C.H. Human schistosomiasis. Lancet 2014, 383, 2253–2264. [Google Scholar] [CrossRef]
  27. Rihet, P.; Demeure, C.E.; Bourgois, A.; Prata, A.; Dessein, A.J. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval ige levels. Eur. J. Immunol. 1991, 21, 2679–2686. [Google Scholar] [CrossRef] [PubMed]
  28. Coulibaly, J.T.; N’Goran, E.K.; Utzinger, J.; Doenhoff, M.J.; Dawson, E.M. A new rapid diagnostic test for detection of anti-Schistosoma mansoni and anti-schistosoma haematobium antibodies. Parasit Vectors 2013, 6, 29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Nausch, N.; Dawson, E.M.; Midzi, N.; Mduluza, T.; Mutapi, F.; Doenhoff, M.J. Field evaluation of a new antibody-based diagnostic for schistosoma haematobium and s. Mansoni at the point-of-care in northeast zimbabwe. BMC Infect. Dis. 2014, 14, 165. [Google Scholar] [CrossRef] [Green Version]
  30. Grenfell, R.; Martins, W.; Silva-Moraes, V.; Araujo, N.; Oliveira, E.; Fonseca, C.; Coelho, P.M. The schistosomula tegument antigen as a potential candidate for the early serological diagnosis of schistosomiasis mansoni. Rev. Inst. Med. Trop. Sao Paulo 2013, 55, 75–78. [Google Scholar] [CrossRef]
  31. Silveira, A.M.; Bethony, J.; Gazzinelli, A.; Kloos, H.; Fraga, L.A.; Alvares, M.C.; Prata, A.; Guerra, H.L.; Loverde, P.T.; Correa-Oliveira, R.; et al. High levels of igg4 to Schistosoma mansoni egg antigens in individuals with periportal fibrosis. Am. J. Trop. Med. Hyg. 2002, 66, 542–549. [Google Scholar] [CrossRef] [Green Version]
  32. Bonnard, P.; Remoue, F.; Schacht, A.M.; Deuffic-Burban, S.; Dompnier, J.P.; Elguero, E.; Charrier, N.; Cassagnou, M.; Diop, M.; Ly, A.; et al. Specific isotype immune response in the diagnosis of human schistosomiasis pathology? Am. J. Trop. Med. Hyg. 2004, 71, 202–205. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Higher levels of SmCTF-specific IgGs in SmPCR+ individuals. Serum samples from all study participants (Sm uninfected n = 60, SmPCR+ n = 62, egg+ n = 108) were analysed for levels of SmCTF-specific antibodies using ELISA technology. The graphs show the optical density of CTF-specific IgG1 (A), IgG2 (B), IgG3 (C), IgG4 (D) and IgE (E). Data are shown as box whiskers with median, interquartile ranges and outliers. Since data were non-parametric, statistical significances between the indicated groups were obtained after Kruskal–Wallis and Mann–Whitney U-tests.
Figure 1. Higher levels of SmCTF-specific IgGs in SmPCR+ individuals. Serum samples from all study participants (Sm uninfected n = 60, SmPCR+ n = 62, egg+ n = 108) were analysed for levels of SmCTF-specific antibodies using ELISA technology. The graphs show the optical density of CTF-specific IgG1 (A), IgG2 (B), IgG3 (C), IgG4 (D) and IgE (E). Data are shown as box whiskers with median, interquartile ranges and outliers. Since data were non-parametric, statistical significances between the indicated groups were obtained after Kruskal–Wallis and Mann–Whitney U-tests.
Pathogens 11 00019 g001
Figure 2. Emerging immune profiles in Sudanese individuals in endemic regions of Schistosoma mansoni. The Schistosoma worm antigen (SWA)-, soluble egg antigen (SEA) and cercarial extract-specific (Sm-CTF) immunoglobulins, age and exposure were compared via regression analyses between the groups, as indicated by the arrows. The SmPCR+ group is characterised by the absence of eggs but the presence of worms. Egg+ individuals are classified by the presence of worms and eggs in their stool, whereas uninfected individuals lack both but live in the same endemic area. The combined “infection per se group” consists of egg+ and SmPCR+ individuals. Indicated profiles demonstrate highly associated schistosome-specific life stage-specific IgG levels.
Figure 2. Emerging immune profiles in Sudanese individuals in endemic regions of Schistosoma mansoni. The Schistosoma worm antigen (SWA)-, soluble egg antigen (SEA) and cercarial extract-specific (Sm-CTF) immunoglobulins, age and exposure were compared via regression analyses between the groups, as indicated by the arrows. The SmPCR+ group is characterised by the absence of eggs but the presence of worms. Egg+ individuals are classified by the presence of worms and eggs in their stool, whereas uninfected individuals lack both but live in the same endemic area. The combined “infection per se group” consists of egg+ and SmPCR+ individuals. Indicated profiles demonstrate highly associated schistosome-specific life stage-specific IgG levels.
Pathogens 11 00019 g002
Table 1. Summary levels of binary multivariable regression analysis between the different patient groups: relation of the covariates SmCTF-specific Igs, age and exposure. The covariate “exposure” refers to the daily water source (e.g., village well or direct from rivers etc.). The covariate “age” was divided into “young” (4–9 years old), “adolescent” (10–19 years old) and “adult” (20–80 years old). An analysis was performed between the three different groups, and the results depict significant parameters with odds ratio (OR), confidence interval (CI) values and p-values. An OR above 1 refers to an association with the group that is listed first; for example, the OR of 6.571 of SmCTF IgG4 in “infected versus uninfected” implies that increases in immunoglobulin (Ig) levels for one unit (optical density (OD)) signifies an association with the infected group. * Values for SmCTF-specific IgG1 and 2 were low and were therefore multiplied by 100 within the regression analysis. PCR = polymerase chain reaction.
Table 1. Summary levels of binary multivariable regression analysis between the different patient groups: relation of the covariates SmCTF-specific Igs, age and exposure. The covariate “exposure” refers to the daily water source (e.g., village well or direct from rivers etc.). The covariate “age” was divided into “young” (4–9 years old), “adolescent” (10–19 years old) and “adult” (20–80 years old). An analysis was performed between the three different groups, and the results depict significant parameters with odds ratio (OR), confidence interval (CI) values and p-values. An OR above 1 refers to an association with the group that is listed first; for example, the OR of 6.571 of SmCTF IgG4 in “infected versus uninfected” implies that increases in immunoglobulin (Ig) levels for one unit (optical density (OD)) signifies an association with the infected group. * Values for SmCTF-specific IgG1 and 2 were low and were therefore multiplied by 100 within the regression analysis. PCR = polymerase chain reaction.
CovariateORConfidence Intervalp Value *
infected versus uninfected
not exposed0.277[0.125–0.612]0.002
age group 0.001
young5.511[2.095–14.499]0.001
adolescent3.812[1.682–8.638]0.001
SmCTF IgG46.571[1.245–34.692]0.027
egg+ versus uninfected
not exposed0.137[0.055–0.345]0.000
age group 0.002
young5.613[1.995–15.794]0.001
adolescent3.136[1.362–7.2200.007
SmPCR+ versus uninfected
age group 0.034
young4.130[1.149–14.849]0.030
adolescent3.502[1.277–9.604]0.015
SmCTF IgG1 × 100 1.262[1.100–1.448]0.001
egg+ versus SmPCR+
not exposed0.204[0.081–0.514]0.001
SmCTF IgG1 × 100 0.793[0.702–0.896]0.000
SmCTF IgG2 × 100 1.152[1.037–1.280]0.008
SmCTF IgG30.001[0.000–0.061]0.002
Table 2. A summary of binary multivariable regression analysis between the different patient groups: relation of the covariates SEA-, SWA- and SmCTF-specific Igs, age and exposure. The covariate “exposure” refers to the daily water source. The covariate “age” was divided into “young” (4–9 years old), “adolescent” (10–19 years old) and “adult” (20–80 years old). Analysis was performed between the three different groups, and the results depict significant parameters with odds ratio (OR), confidence interval (CI) values and p -values. An OR above 1 refers to an association with the group that is listed first; for example, the OR of 14.816 of SEA IgG4 in “infected versus uninfected” implies that increases in immunoglobulin (Ig) levels for one unit (optical density (OD)) signifies an association with the infected group. * Values for SWA-specific IgG3, SmCTF-specific IgG1 and 2 were low and were therefore multiplied by 100 within the regression analysis. PCR = polymerase chain reaction.
Table 2. A summary of binary multivariable regression analysis between the different patient groups: relation of the covariates SEA-, SWA- and SmCTF-specific Igs, age and exposure. The covariate “exposure” refers to the daily water source. The covariate “age” was divided into “young” (4–9 years old), “adolescent” (10–19 years old) and “adult” (20–80 years old). Analysis was performed between the three different groups, and the results depict significant parameters with odds ratio (OR), confidence interval (CI) values and p -values. An OR above 1 refers to an association with the group that is listed first; for example, the OR of 14.816 of SEA IgG4 in “infected versus uninfected” implies that increases in immunoglobulin (Ig) levels for one unit (optical density (OD)) signifies an association with the infected group. * Values for SWA-specific IgG3, SmCTF-specific IgG1 and 2 were low and were therefore multiplied by 100 within the regression analysis. PCR = polymerase chain reaction.
CovariateORConfidence Intervalp Value *
infected versus uninfected
not exposed0.282[0.113–0.707]0.007
age group 0.037
young3.582[1.223–10.490]0.020
adolescent2.750[1.055–7.172]0.039
SEA IgG414.816[5.956–36.885]0.000
egg+ versus uninfected
not exposed0.185[0.065–0.528]0.002
SWA IgG20.170[0.023–1.239]0.080
SmCTF IgG40.019[0.002–0.220]0.002
SEA IgG449.667[12.957–190.384]0.000
SmPCR+ versus uninfected
age group 0.011
young10.727[2.009–57.263]0.005
adolescent5.228[1.454–18.794]0.011
SEA IgG428.818[6.700–123.964]0.000
SEA IgE0.102[0.011–0.960]0.046
SWA IgG3 × 1001.418[1.176–1.710]0.000
egg+ versus SmPCR+
not exposed0.124[0.042–0.367]0.000
SEA IgG43.095[1.111–8.619]0.031
SEA IgE12.212[1.580–94.354]0.016
SmCTF IgG1 × 100 0.802[0.698–0.921]0.002
SmCTF IgG2 × 100 1.150[1.028–1.287]0.015
SmCTF IgG30.000[0.000–0.018]0.001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Arndts, K.; Elfaki, T.E.M.; Doenhoff, M.J.; Katawa, G.; Goreish, I.A.; Atti El Mekki, M.E.Y.A.; Hoerauf, A.; Ritter, M.; Layland, L.E. Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages. Pathogens 2022, 11, 19. https://doi.org/10.3390/pathogens11010019

AMA Style

Arndts K, Elfaki TEM, Doenhoff MJ, Katawa G, Goreish IA, Atti El Mekki MEYA, Hoerauf A, Ritter M, Layland LE. Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages. Pathogens. 2022; 11(1):19. https://doi.org/10.3390/pathogens11010019

Chicago/Turabian Style

Arndts, Kathrin, Tayseer E. M. Elfaki, Michael J. Doenhoff, Gnatoulma Katawa, Ibtisam A. Goreish, Misk El Yemen A. Atti El Mekki, Achim Hoerauf, Manuel Ritter, and Laura E. Layland. 2022. "Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages" Pathogens 11, no. 1: 19. https://doi.org/10.3390/pathogens11010019

APA Style

Arndts, K., Elfaki, T. E. M., Doenhoff, M. J., Katawa, G., Goreish, I. A., Atti El Mekki, M. E. Y. A., Hoerauf, A., Ritter, M., & Layland, L. E. (2022). Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages. Pathogens, 11(1), 19. https://doi.org/10.3390/pathogens11010019

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop